Acinetobacter baumannii clinical isolates from outbreaks in Erbil hospitals after the COVID-19 pandemic
The Journal of Infection in Developing Countries · 2024
DOI: 10.3855/jidc.17885 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Infection in Developing Countries, 2024. Verfasst von Hazheer M Hamad und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biology, Faculty of science and health, Koya University, Koya KOY45, Kurdistan Region - F.R. Iraq. Hauptthemen laut MEDLINE: Acinetobacter baumannii, COVID-19, Acinetobacter Infections, Drug Resistance, Multiple, Bacterial. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Introduction
Acinetobacter baumannii is endemic in hospital environments, and since the coronavirus disease 2019 (COVID-19) pandemic, multidrug-resistant A. baumannii has become more potent. This potential evolution is driven by the undetectable numbers of gene resistances it has acquired. We evaluated the antibiotic-resistance genes in isolates from patients in Erbil hospitals. Methodology: This is the first study to demonstrate the antimicrobial resistance epidemic in Erbil, Iraq. A total of 570 patients, including 100 COVID-19 patients were tested. Isolate identification, characterization, antibiotics susceptibility test, polymerase chain reaction (PCR) amplification of the antibiotic resistance genes in both bacterial chromosome and plasmid, 16S-23S rRNA gene intergenic spacer (ITS) sequencing using the Sanger DNA sequencing, and phylogenetic analysis were used in this study.
Results
Only 13% of A. baumannii isolates were from COVID-19 patients. All isolates were multi-drug resistant due because of 24 resistance genes located in both the bacterial chromosome or the plasmid. blaTEM gene was detected in the isolates; however, aadB was not detected in the isolated bacteria. New carbapenemase genes were identified by Sanger sequencing and resistance genes were acquired by plasmids.
Conclusions
The study identified metabolic differences in the isolates; although all the strains used the coumarate pathway to survive. Several resistance genes were present in the isolates’ plasmids and chromosome. There were no strong biofilm producers. The role of the plasmid in A. baumannii resistance development was described based on the results.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biology, Faculty of science and health, Koya University, Koya KOY45, Kurdistan Region - F.R. Iraq.
Zitieren
APA
Hamad, H. M., & Subhi, H. T. (2024). Acinetobacter baumannii clinical isolates from outbreaks in Erbil hospitals after the COVID-19 pandemic. The Journal of Infection in Developing Countries. https://doi.org/10.3855/jidc.17885
Vancouver
Hamad HM, Subhi HT. Acinetobacter baumannii clinical isolates from outbreaks in Erbil hospitals after the COVID-19 pandemic. The Journal of Infection in Developing Countries. 2024. doi:10.3855/jidc.17885
BibTeX
@article{Hamad2024,
author = {Hamad, Hazheer M and Subhi, Hanan T},
title = {Acinetobacter baumannii clinical isolates from outbreaks in Erbil hospitals after the COVID-19 pandemic},
journal = {The Journal of Infection in Developing Countries},
year = {2024},
doi = {10.3855/jidc.17885}
}
EUVIMED